Meet the mastermind between the two top ETFs in the cannabis and emerging psychedelics industry…

For cannabis investors who are new to the industry, there are two types of investments that I would recommend above all others – multistate operators (MSOs) and exchange-traded funds (ETFs).

MSOs, which are United States cannabis operators doing business in more than one state, are hands down the best cannabis companies to own (here’s why).

On the flip side, ETFs – which are a basket of stocks rolled up into one ticker – are a great way for investors to get broad exposure to all of the moneymaking that this industry has to offer by owning its top operators all at once.

Of course, you shouldn’t invest in just any MSO or ETF… You have to know how to separate the winners from the wannabes.

That’s why you have the National Institute for Cannabis Investors (NICI) in your corner to do the heavy lifting for you.

And with AdvisorShares Pure US Cannabis ETF (NYSE: MSOS), an ETF stacked with all of the best MSOs to own in the booming U.S. cannabis market, you can get the best of both worlds.

The same goes for AdvisorShares Psychedelics ETF (NYSE: PSIL), an ETF that gives investors exposure to the top players in the emerging psychedelics industry plus some of the best cannabis stocks.

Get immediate access to the best psychedelic investing opportunities this industry has to offer with this report on 23 tiny stocks with massive moneymaking potential. Click here to claim your copy.

I’ve written to you before about why MSOS is a great stock to own right now, but the best way to show you is to get the man behind the ETF – Dan Ahrens – to tell you himself. Dan is the Chief Operating Officer of AdvisorShares ETFs and the mastermind behind both MSOS and PSIL.

During our one-on-one, Dan revealed his theory behind these ETFs and what kind of moneymaking investors gain access to by owning shares of an industry’s top companies all at once.

He also shared his own cannabis market predictions for 2022.

This interview you’re about to watch was first sent to our paid NICI Membership subscribers.

But what Dan had to say was so important that I wanted to make sure all our NICI readers could access it right here…

My team just finished up a comprehensive investment dossier on MSOS and the opportunity it presents for investors in 2022, which will be available exclusively to NICI Membership subscribers next week. (So, current members – make sure you watch your inbox for that as soon as it’s released!)

If you’re not yet a member, you can still make sure you’re among the first to receive the report by clicking here to join NICI Membership today.

To your investing success,

Danny Brody
Executive Director, National Institute for Cannabis Investors


Comments

One response to “Here’s Why These 2 ETFs Are Some of the Hottest Pot Stocks to Own for 2022 (Dan Ahrens Interview)”

  1. Would have been nice to have gotten Dan’s personal recommendations on which 3 cannabis stocks he himself would purchase right now for his own personal account based on potential, value and growth in the interview.

Leave a Reply

Your email address will not be published. Required fields are marked *